Glpg0492 is under investigation in clinical trial NCT01130818 (First-in-Human Single Ascending Dose of GLPG0492).
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Cyclosporine | The risk or severity of liver damage can be increased when GLPG-0492 is combined with Cyclosporine. |
| Dicoumarol | GLPG-0492 may increase the anticoagulant activities of Dicoumarol. |
| Phenindione | GLPG-0492 may increase the anticoagulant activities of Phenindione. |
| Warfarin | GLPG-0492 may increase the anticoagulant activities of Warfarin. |
| Phenprocoumon | GLPG-0492 may increase the anticoagulant activities of Phenprocoumon. |
| Acenocoumarol | GLPG-0492 may increase the anticoagulant activities of Acenocoumarol. |
| 4-hydroxycoumarin | GLPG-0492 may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Coumarin | GLPG-0492 may increase the anticoagulant activities of Coumarin. |
| (R)-warfarin | GLPG-0492 may increase the anticoagulant activities of (R)-warfarin. |
| Ethyl biscoumacetate | GLPG-0492 may increase the anticoagulant activities of Ethyl biscoumacetate. |
| Fluindione | GLPG-0492 may increase the anticoagulant activities of Fluindione. |
| Clorindione | GLPG-0492 may increase the anticoagulant activities of Clorindione. |
| Diphenadione | GLPG-0492 may increase the anticoagulant activities of Diphenadione. |
| Tioclomarol | GLPG-0492 may increase the anticoagulant activities of Tioclomarol. |
| (S)-Warfarin | GLPG-0492 may increase the anticoagulant activities of (S)-Warfarin. |
| Insulin human | GLPG-0492 may increase the hypoglycemic activities of Insulin human. |
| Insulin lispro | GLPG-0492 may increase the hypoglycemic activities of Insulin lispro. |
| Insulin glargine | GLPG-0492 may increase the hypoglycemic activities of Insulin glargine. |
| Insulin pork | GLPG-0492 may increase the hypoglycemic activities of Insulin pork. |
| Troglitazone | GLPG-0492 may increase the hypoglycemic activities of Troglitazone. |
| Glimepiride | GLPG-0492 may increase the hypoglycemic activities of Glimepiride. |
| Sulfisoxazole | GLPG-0492 may increase the hypoglycemic activities of Sulfisoxazole. |
| Disopyramide | GLPG-0492 may increase the hypoglycemic activities of Disopyramide. |
| Acarbose | GLPG-0492 may increase the hypoglycemic activities of Acarbose. |
| Metformin | GLPG-0492 may increase the hypoglycemic activities of Metformin. |
| Sulfadiazine | GLPG-0492 may increase the hypoglycemic activities of Sulfadiazine. |
| Rosiglitazone | GLPG-0492 may increase the hypoglycemic activities of Rosiglitazone. |
| Acetohexamide | GLPG-0492 may increase the hypoglycemic activities of Acetohexamide. |
| Quinine | GLPG-0492 may increase the hypoglycemic activities of Quinine. |
| Miglitol | GLPG-0492 may increase the hypoglycemic activities of Miglitol. |
| Chlorpropamide | GLPG-0492 may increase the hypoglycemic activities of Chlorpropamide. |
| Nateglinide | GLPG-0492 may increase the hypoglycemic activities of Nateglinide. |
| Pentamidine | GLPG-0492 may increase the hypoglycemic activities of Pentamidine. |
| Mifepristone | GLPG-0492 may increase the hypoglycemic activities of Mifepristone. |
| Tolazamide | GLPG-0492 may increase the hypoglycemic activities of Tolazamide. |
| Repaglinide | GLPG-0492 may increase the hypoglycemic activities of Repaglinide. |
| Phenformin | GLPG-0492 may increase the hypoglycemic activities of Phenformin. |
| Sulfamethoxazole | GLPG-0492 may increase the hypoglycemic activities of Sulfamethoxazole. |
| Glyburide | GLPG-0492 may increase the hypoglycemic activities of Glyburide. |
| Glipizide | GLPG-0492 may increase the hypoglycemic activities of Glipizide. |
| Gliclazide | GLPG-0492 may increase the hypoglycemic activities of Gliclazide. |
| Tolbutamide | GLPG-0492 may increase the hypoglycemic activities of Tolbutamide. |
| Pioglitazone | GLPG-0492 may increase the hypoglycemic activities of Pioglitazone. |
| Bromocriptine | GLPG-0492 may increase the hypoglycemic activities of Bromocriptine. |
| Gliquidone | GLPG-0492 may increase the hypoglycemic activities of Gliquidone. |
| Mitiglinide | GLPG-0492 may increase the hypoglycemic activities of Mitiglinide. |
| Sitagliptin | GLPG-0492 may increase the hypoglycemic activities of Sitagliptin. |
| Sunitinib | GLPG-0492 may increase the hypoglycemic activities of Sunitinib. |
| Exenatide | GLPG-0492 may increase the hypoglycemic activities of Exenatide. |
| Mecasermin | GLPG-0492 may increase the hypoglycemic activities of Mecasermin. |
| Pramlintide | GLPG-0492 may increase the hypoglycemic activities of Pramlintide. |
| Glisoxepide | GLPG-0492 may increase the hypoglycemic activities of Glisoxepide. |
| Insulin aspart | GLPG-0492 may increase the hypoglycemic activities of Insulin aspart. |
| Insulin detemir | GLPG-0492 may increase the hypoglycemic activities of Insulin detemir. |
| Insulin glulisine | GLPG-0492 may increase the hypoglycemic activities of Insulin glulisine. |
| Glymidine | GLPG-0492 may increase the hypoglycemic activities of Glymidine. |
| AICA ribonucleotide | GLPG-0492 may increase the hypoglycemic activities of AICA ribonucleotide. |
| Buformin | GLPG-0492 may increase the hypoglycemic activities of Buformin. |
| Vildagliptin | GLPG-0492 may increase the hypoglycemic activities of Vildagliptin. |
| Voglibose | GLPG-0492 may increase the hypoglycemic activities of Voglibose. |
| NN344 | GLPG-0492 may increase the hypoglycemic activities of NN344. |
| AMG-222 | GLPG-0492 may increase the hypoglycemic activities of AMG-222. |
| Bisegliptin | GLPG-0492 may increase the hypoglycemic activities of Bisegliptin. |
| Alogliptin | GLPG-0492 may increase the hypoglycemic activities of Alogliptin. |
| Dapagliflozin | GLPG-0492 may increase the hypoglycemic activities of Dapagliflozin. |
| Saxagliptin | GLPG-0492 may increase the hypoglycemic activities of Saxagliptin. |
| Liraglutide | GLPG-0492 may increase the hypoglycemic activities of Liraglutide. |
| Gosogliptin | GLPG-0492 may increase the hypoglycemic activities of Gosogliptin. |
| Linagliptin | GLPG-0492 may increase the hypoglycemic activities of Linagliptin. |
| Canagliflozin | GLPG-0492 may increase the hypoglycemic activities of Canagliflozin. |
| Glibornuride | GLPG-0492 may increase the hypoglycemic activities of Glibornuride. |
| Benfluorex | GLPG-0492 may increase the hypoglycemic activities of Benfluorex. |
| Empagliflozin | GLPG-0492 may increase the hypoglycemic activities of Empagliflozin. |
| Albiglutide | GLPG-0492 may increase the hypoglycemic activities of Albiglutide. |
| Dulaglutide | GLPG-0492 may increase the hypoglycemic activities of Dulaglutide. |
| Lobeglitazone | GLPG-0492 may increase the hypoglycemic activities of Lobeglitazone. |
| Netoglitazone | GLPG-0492 may increase the hypoglycemic activities of Netoglitazone. |
| Rivoglitazone | GLPG-0492 may increase the hypoglycemic activities of Rivoglitazone. |
| Ciglitazone | GLPG-0492 may increase the hypoglycemic activities of Ciglitazone. |
| Lixisenatide | GLPG-0492 may increase the hypoglycemic activities of Lixisenatide. |
| Insulin beef | GLPG-0492 may increase the hypoglycemic activities of Insulin beef. |
| Insulin degludec | GLPG-0492 may increase the hypoglycemic activities of Insulin degludec. |
| Insulin peglispro | GLPG-0492 may increase the hypoglycemic activities of Insulin peglispro. |
| Insulin tregopil | GLPG-0492 may increase the hypoglycemic activities of Insulin tregopil. |
| Ipragliflozin | GLPG-0492 may increase the hypoglycemic activities of Ipragliflozin. |
| Dutogliptin | GLPG-0492 may increase the hypoglycemic activities of Dutogliptin. |
| Allicin | GLPG-0492 may increase the hypoglycemic activities of Allicin. |
| Tofogliflozin | GLPG-0492 may increase the hypoglycemic activities of Tofogliflozin. |
| Ertugliflozin | GLPG-0492 may increase the hypoglycemic activities of Ertugliflozin. |
| 2,4-thiazolidinedione | GLPG-0492 may increase the hypoglycemic activities of 2,4-thiazolidinedione. |
| Teneligliptin | GLPG-0492 may increase the hypoglycemic activities of Teneligliptin. |
| Omarigliptin | GLPG-0492 may increase the hypoglycemic activities of Omarigliptin. |
| Carmegliptin | GLPG-0492 may increase the hypoglycemic activities of Carmegliptin. |
| Gemigliptin | GLPG-0492 may increase the hypoglycemic activities of Gemigliptin. |
| Anagliptin | GLPG-0492 may increase the hypoglycemic activities of Anagliptin. |
| Evogliptin | GLPG-0492 may increase the hypoglycemic activities of Evogliptin. |
| Sotagliflozin | GLPG-0492 may increase the hypoglycemic activities of Sotagliflozin. |
| Balaglitazone | GLPG-0492 may increase the hypoglycemic activities of Balaglitazone. |
| Remogliflozin etabonate | GLPG-0492 may increase the hypoglycemic activities of Remogliflozin etabonate. |
| Carbutamide | GLPG-0492 may increase the hypoglycemic activities of Carbutamide. |